Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Biologics Market Outlook to 2018
     3.1 Market Size
     3.2 Market Segmentation

4. Market Trends & Drivers
     4.1 Emerging Markets to Play a Pivotal Role in the Growth of Biosimilars
     4.2 Rising Business Alliances Aiding in Biosimilar Development
     4.3 Governments Realizing the Potential in Biosimilars, Encouraging Industry Growth

5. Biosimilars Market Outlook to 2018
     5.1 Market Size
     5.2 Market Segmentation
            5.2.1 Erythropoietin
                       5.2.1.1 Scientific Insight
                       5.2.1.2 Market Analysis
                       5.2.1.3 Recent Activities
            5.2.2 Human Growth Hormone
                       5.2.2.1 Scientific Insight
                       5.2.2.2 Market Analysis
                       5.2.2.3 Recent Activities
            5.2.3 G-CSF
                       5.2.3.1 Scientific Insight
                       5.2.3.2 Market Analysis
                       5.2.3.3 Recent Activities
            5.2.4 Monoclonal Antibody
                       5.2.4.1 Scientific Insight
                       5.2.4.2 Market Analysis
                       5.2.4.3 Recent Activities
            5.2.5 Human Insulin
                       5.2.5.1 Scientific Insight
                       5.2.5.2 Market Analysis
                       5.2.5.3 Recent Activities
            5.2.6 Interferons
                       5.2.6.1 Scientific Insight
                       5.2.6.2 Market Analysis

6. Major Geographical Market
     6.1 US
            6.1.1 Market Analysis
            6.1.2 Regulatory Analysis
            6.1.3 Recent Activities
     6.2 Europe
            6.2.1 Market Analysis
            6.2.2 Regulatory Analysis
            6.2.3 Recent Activities
     6.3 India
            6.3.1 Market Analysis
            6.3.2 Regulatory Analysis
            6.3.3 Recent Activities
     6.4 China
            6.4.1 Market Analysis
            6.4.2 Regulatory Analysis
            6.4.3 Recent Activities
     6.5 Korea
            6.5.1 Market Analysis
            6.5.2 Regulatory Analysis
            6.5.3 Recent Activities

7. Competitive Landscape (Key Products & Recent Activities)
     7.1 US
            7.1.1 Hospira
     7.2 Europe
            7.2.1 Stada Arzneimittel
            7.2.2 Hexal AG
            7.2.3 Ratiopharm GmbH
            7.2.4 Sandoz GmbH
            7.2.5 Bioton
     7.3 India
            7.3.1 Dr.Reddy's Labs (DRL)
            7.3.2 Intas Pharmaceuticals Ltd.
            7.3.3 Biocon Limited
            7.3.4 Wockhardt Limited
            7.3.5 Shantha Biotechnics Limited
            7.3.6 Reliance Life Sciences
     7.4 China
            7.4.1 3 SBio Inc.
     7.5 Korea
            7.5.1 LG Life Sciences
            7.5.2 Celltrion Pharm Inc.
            7.5.3 Dong-A Pharmaceutical Co., Ltd
     7.6 Others
            7.6.1 Teva